All Stories

  1. How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway
  2. Case of the Month from University of Melbourne, Australia: refractory chyle leak after retroperitoneal lymph node dissection with updated algorithm
  3. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy
  4. The Pen is Mightier than the Machine ‐ Artificial Intelligence Image Generators in Urology
  5. Is genetic testing coming of age in advanced prostate cancer?
  6. Government Funding of FDG‐PET Imaging In Rare Urological Cancers‐ Better Data, Better Outcomes.
  7. Decade‐long trends in prostate cancer biopsy grade groups and treatment within a population‐based registry
  8. New Approaches to Targeting Epigenetic Regulation in Bladder Cancer
  9. Point-Counterpoint: Active Surveillance in the “Real World” Has Far More Risks Than We Appreciate
  10. Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports
  11. Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer
  12. Case of the Month from Peter MacCallum Cancer Centre, Melbourne, Australia: ICG‐assisted robotic Boari flap ureteric reimplantation in a case of missed ureteric injury
  13. Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer—A Prospective Cohort Study
  14. Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study
  15. Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
  16. Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?
  17. Active involvement of nursing staff in reporting and grading complication‐intervention events—Protocol and results of the CAMUS Pilot Nurse Delphi Study
  18. PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer—A Prospective Study of Men with 3 Year Follow Up
  19. Cribriform pattern disease over‐represented in pelvic lymph node metastases identified on 68GA PSMA‐PET/CT
  20. A glass half‐full: positive impacts of the COVID‐19 pandemic on the delivery of public hospital urology care
  21. Effect of local steroids on urethral strictures: A systematic review and meta-analysis
  22. Online urological educational material for medical students: can search engines be trusted?
  23. Self‐reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population‐based registry
  24. Irreversible Electroporation for Prostate Cancer
  25. Long‐term oncological outcomes of the Agarwal loop‐ligation technique for management of the distal ureter during laparoscopic radical nephroureterectomy
  26. In reply: an example of the evolution of evidence in a new disease
  27. Implications of COVID-19 on urological laparoscopic surgery
  28. Subinguinal orchiectomy—A minimally invasive approach to open surgery
  29. Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
  30. Review of the use of prophylactic drain tubes post‐robotic radical prostatectomy: Dogma or decent practice?
  31. A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer
  32. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer
  33. Can online support groups address psychological morbidity of cancer patients? An artificial intelligence based investigation of prostate cancer trajectories
  34. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic re...
  35. Less, not More, Antibiotics Please
  36. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment
  37. Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives
  38. Prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT)‐guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single‐institution experience and review of the published literature
  39. Erectile dysfunction: a global review of intracavernosal injectables
  40. Primary transitional cell carcinoma of penis – A rare presentation
  41. Men’s health on the web: an analysis of current resources
  42. Quality of Health Information on the Internet for Prostate Cancer
  43. Robotic-assisted vs. open radical prostatectomy: A machine learning framework for intelligent analysis of patient-reported outcomes from online cancer support groups
  44. Current management of radiation cystitis: a review and practical guide to clinical management
  45. Bladder cancer surveillance in patients with spinal cord injuries
  46. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
  47. Machine learning to support social media empowered patients in cancer care and cancer treatment decisions
  48. Intra‐operative cell salvage in urological surgery: a systematic review and meta‐analysis of comparative studies
  49. Exploring pathways towards improving patient experience of robot-assisted radical prostatectomy (RARP): assessing patient satisfaction and attitudes
  50. Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
  51. Magnetic resonance imaging cognitive fusion biopsy – is near enough good enough?
  52. The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data
  53. Age Related Differences in Responsiveness to Sildenafil and Tamsulosin are due to Myogenic Smooth Muscle Tone in the Human Prostate
  54. Is choline‐based PET imaging still relevant in recurrent prostate cancer?
  55. Prostate-specific membrane antigen radioguided surgery: a promising utility
  56. Transperineal prostate biopsy - tips for analgesia
  57. Thoracic Surgery Information on the Internet: A Multilingual Quality Assessment
  58. Bringing clarity or confusion? The role of prostate‐specific membrane antigen positron‐emission/computed tomography for primary staging in prostate cancer
  59. ‘ProtecTion’ from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?
  60. Understanding the role of new systemic agents in the treatment of prostate cancer
  61. Cytoreductive surgery for men with metastatic prostate cancer
  62. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate‐specific antigen (PSA) testing on PSA testing in Australia
  63. Prostate Imaging Reporting and Data System score of four or more: active surveillance no more
  64. Guideline of guidelines: follow‐up after nephrectomy for renal cell carcinoma
  65. Response to “Twitter-Based Journal Clubs: Some Additional Facts and Clarifications”
  66. Orthotopic neobladder reconstruction
  67. Looking forward, looking back—10 years in urology
  68. The emerging use of Twitter by urological journals
  69. Urological Society of Australia and New Zealand's alignment with the BJU International: a collaborative success magnified by a supplement journal
  70. A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression
  71. Uro‐oncology multidisciplinary meetings at an Australian tertiary referral centre – impact on clinical decision‐making and implications for patient inclusion
  72. Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes
  73. Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register
  74. Fournier?s gangrene - delayed pedicle flap based upon the anterior abdominal wall
  75. Fragmentation of Transrectal Ultrasound–guided Biopsy Cores Is Influenced by the Method of Specimen Retrieval
  76. Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens
  77. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
  78. Radiation within urology: challenges and triumphs
  79. Fiducial markers and spacers in prostate radiotherapy: current applications
  80. 18F-fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive Bladder Cancer
  81. The dilemmas of prostate cancer screening
  82. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia
  83. Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?
  84. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
  85. Metaplastic conditions of the bladder
  86. Effectiveness of epidural versus alternate analgesia for pain relief after radical prostatectomy and correlation with biochemical recurrence in men with prostate cancer
  87. Transperineal biopsy of the prostate—is this the future?
  88. Should Follow-up Biopsies for Men on Active Surveillance for Prostate Cancer Be Restricted to Limited Templates?
  89. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer
  90. The role of magnetic resonance imaging in prostate cancer
  91. Orthotopic Bladder Substitution (Neobladder)
  92. Current Role of PET, CT, MR for Invasive Bladder Cancer
  93. Nephrectomy for a Renal Metastasis of Undiagnosed Hepatocellular Carcinoma Arising From an Orthotopic Liver Transplant Undertaken for Cryptogenic Cirrhosis
  94. Spermatocytic Seminoma With Sarcoma: An Indication for Adjuvant Chemotherapy in Localized Disease
  95. Urothelial carcinoma of the bladder with asynchronous metastases to both testes
  96. A smoking cessation program as a resource for bladder cancer
  97. Editorial Comment
  98. PET in Prostate and Bladder Tumors
  99. Humour and urology: “Nota bene dick doc”
  100. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue
  101. Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study
  102. Saving Nephrons: Current Surgical Options in Partial Nephrectomy
  103. An Investigation of the Basic Physics of Irrigation in Urology and the Role of Automated Pump Irrigation in Cystoscopy
  104. Commentary on “Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: A large North American experience.” Lawrentschuk N, Zuniga A, Grabowksi AC, Rendon RA, Jewett MA, Division of Urology, Departm...
  105. Effects of Partial Nephrectomy on Postoperative Blood Pressure
  106. Incidence of Bladder Cancer in Sri Lanka: Analysis of the Cancer Registry Data and Review of the Incidence of Bladder Cancer in the South Asian Population
  107. Oncology Health Information Quality on the Internet: a Multilingual Evaluation
  108. The pursuit of the “perfect” biomarker in prostate cancer
  109. Penile lichen sclerosus (balanitis xerotica obliterans)
  110. Re: Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer
  111. Prevention and management of TURP-related hemorrhage
  112. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124I-cG250 PET/CT
  113. Consumerism and its impact on robotic-assisted radical prostatectomy
  114. Evolution from active surveillance to focal therapy in the management of prostate cancer
  115. Surgical margin status among men with organ-confined (pT2) prostate cancer: a population-based study
  116. Active surveillance for low-risk prostate cancer: an update
  117. Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort
  118. Evolution of the USANZ tie
  119. Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer
  120. Lessons learned: end‐user assessment of a skills laboratory based training programme for urology trainees
  121. An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer
  122. Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence
  123. Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer
  124. Partial Orchiectomy for Presumed Malignancy in Patients With a Solitary Testis Due to a Prior Germ Cell Tumor: A Large North American Experience
  125. Realistic Anatomical Prostate Models for Surgical Skills Workshops Using Ballistic Gelatin for Nerve-Sparing Radical Prostatectomy and Fruit for Simple Prostatectomy
  126. The Role of Lymph Node Fine-Needle Aspiration in Penile Cancer in the Sentinel Node Era
  127. Recent advances in magnetic resonance imaging of prostate cancer
  128. Role of positron emission tomography in urological oncology
  129. Prostate cancer immunology – an update for Urologists
  130. Image guidance for focal therapy of prostate cancer
  131. Diagnosis of Bone Metastases in Urological Malignancies—An Update
  132. MRI for men undergoing active surveillance or with rising PSA and negative biopsies
  133. Prevention and management of complications following radical cystectomy for bladder cancer
  134. Focal therapy in prostate cancer: modalities, findings and future considerations
  135. [18F]‐fluorocholine positron‐emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study
  136. Organ-sparing approaches for testicular masses
  137. Radical prostatectomy in obese patients: Improved surgical outcomes in recent years
  138. Construction and Evaluation of an Anatomically Correct Multi-Image Modality Compatible Phantom for Prostate Cancer Focal Ablation
  139. Creation and Validation of a Visual Macroscopic Hematuria Scale for Optimal Communication and an Objective Hematuria Index
  140. Cystectomy in Patients With Spinal Cord Injury: Indications and Long-Term Outcomes
  141. Prostate-specific antigen test result interpretation when combined with risk factors for recommendation of biopsy: a survey of urologist’s practice patterns
  142. Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging Accuracy
  143. Laparoscopic Lens Fogging: A Review of Etiology and Methods to Maintain a Clear Visual Field
  144. Potential of imaging biomarkers for characterization of renal masses
  145. Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer
  146. Re: Polyorchidism: A Meta-Analysis
  147. Imaging renal cell carcinoma with ultrasonography, CT and MRI
  148. Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models
  149. Focal Laser Ablation for Localized Prostate Cancer
  150. Functional imaging of renal cell carcinoma
  151. Investigating Contamination of Phytotherapy Products for Benign Prostatic Hyperplasia With α-Blockers and 5α-Reductase Inhibitors
  152. Re: Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails
  153. Tumor Volume in Radical Prostatectomy Specimens Assessed by Digital Image Analysis Software Correlates With Other Prognostic Factors
  154. ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging
  155. Improving informed consent for patients undergoing radical prostatectomy using multimedia techniques: a prospective randomized crossover study
  156. AN INTERACTIVE MULTIMEDIA APPROACH TO UROLOGICAL ANATOMY
  157. Clinical significance of the positive surgical margin based upon location, grade, and stage
  158. Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
  159. Imaging of Bone Metastases
  160. Nutraceuticals and prostate cancer prevention: a current review
  161. Operator is an Independent Predictor of Detecting Prostate Cancer at Transrectal Ultrasound Guided Prostate Biopsy
  162. Urinary catheter balloons should only be filled with water: testing the myth
  163. Health Information Quality on the Internet in Urological Oncology: A Multilingual Longitudinal Evaluation
  164. Placenta Percreta With Urinary Tract Involvement: The Case for a Multidisciplinary Approach
  165. Reply
  166. Clinical stage I seminoma: the case for surveillance
  167. Draping and associated equipment for indwelling catheter manipulation by hospital staff: an assessment of attitudes and adequacy
  168. Anatomic Considerations for Radical Retropubic Prostatectomy in an Achondroplastic Dwarf
  169. Severe Irritant Contact Dermatitis Causing Skin Ulceration Secondary to a Testosterone Patch
  170. Peripheral Primitive Neuroectodermal Tumor Arising from the Seminal Vesicle
  171. Renal cell carcinoma: imaging and therapy
  172. Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship
  173. Fluorine-18 Fluorothymidine: A New Positron Emission Radioisotope for Renal Tumors
  174. Delineating the anatomy of oncologic postradiation vesicovaginal fistulae with reconstructed computed tomography
  175. Fine‐needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma
  176. Metachronous metastasis to the penis from carcinoma of the rectum
  177. Positron emission tomography and molecular imaging of the prostate: an update
  178. An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy
  179. Sclerosing Lipogranuloma of the Genitalia Treated with Corticosteroids
  180. Xenografting Tumour beneath the Renal Capsule Using Modern Surgical Equipment
  181. Peritoneal “pillowcase” for the displaced spleen post-distal pancreatectomy
  182. Sterile disposable sheath system for flexible cystoscopes
  183. Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography
  184. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review
  185. Outcome from percutaneous nephrolithotomy in patients with spinal cord injury, using a single‐stage dilator for access
  186. EFFECTIVENESS OF CYPROTERONE ACETATE IN ACHIEVING CASTRATION AND PREVENTING LUTEINIZING HORMONE RELEASING HORMONE ANALOGUE INDUCED TESTOSTERONE SURGE IN PATIENTS WITH PROSTATE CANCER
  187. CAUDA EQUINA SYNDROME SECONDARY TO CONSTIPATION: AN UNCOMMON OCCURRENCE
  188. Inserting testicular prostheses: a new surgical technique for difficult cases
  189. Erratum
  190. Metastatic Breast Cancer to the Bladder
  191. Occult renal segmental arterial injury after trauma
  192. Fenestrated urethral catheter to aid anastomotic drainage after radical prostatectomy
  193. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy
  194. Polyorchidism: a case report and review of the literature
  195. Functional imaging of intratumoral hypoxia
  196. Implications of amyloidosis on prostatic biopsy
  197. Use of holmium laser for removal of an intraluminal ureteric suture
  198. Suprapubic stab cystostomy
  199. SPONTANEOUS BLADDER WALL ABSCESS
  200. Ureteric stenting 25 years on: routine or risky?
  201. Suprapubic stab cystostomy: a safer technique
  202. ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY: IMPLICATIONS OF PROLONGED WAITING TIMES FOR SURGERY
  203. Necrotizing fasciitis: an unusual presentation for rectal carcinoma
  204. Spontaneous intracerebral haemorrhages—warfarin as a risk factor
  205. Testicular microlithiasis: a case report and review of the literature
  206. Dressing size and pain: A prospective trial
  207. Percutaneous Transluminal Angioplasty of Stenosis at the Common Iliac Artery Origin Using a Single Balloon Technique
  208. Wound blisters post hip surgery: A prospective trial comparingdressings